Literature DB >> 33007299

Reproductive tract immune cells from pregnant women or those using depot medroxyprogesterone acetate show no excess susceptibility to HIV-1: Results of an ex vivo fusion assay.

Dominika Seidman1, Marielle Cavrois2, Joan F Hilton3, Nadia R Roan4, Sarah Averbach5, Margaret Takeda6, Eric Chang2, Nandhini Raman7, Ruth Greenblatt8, Barbara L Shacklett9, Karen Smith-McCune10.   

Abstract

INTRODUCTION: Ex vivo fusion assays offer an efficient method for studying HIV-1 entry associated with contraceptive use and pregnancy outside of cohort studies of HIV-1 incidence.
METHODS: We measured ex vivo HIV-1 fusion to cervical or endometrial immune cells from three groups of women: pregnant, non-pregnant not using hormonal or intrauterine contraception, and using depot medroxyprogesterone acetate (DMPA). RESULTS AND
CONCLUSIONS: There was no excess susceptibility to HIV-1 fusion of cells from pregnant women or DMPA users compared to controls. Although the number of target cells in endometrium was higher in DMPA users compared to controls, HIV-1 fusion was lower. IMPLICATIONS: In ex vivo assays, HIV-1 showed no enhanced fusion to cervical immune cells from pregnant women or DMPA users compared to controls, and lower fusion to endometrial immune cells from DMPA users. This assay is useful for studying hormonal and contraceptive effects on HIV-1 entry into reproductive tract immune cells.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Contraception and HIV-1 risk; HIV-1 fusion assay; Pregnancy and HIV-1 risk; Reproductive tract HIV-1 target cells

Mesh:

Substances:

Year:  2020        PMID: 33007299      PMCID: PMC7736211          DOI: 10.1016/j.contraception.2020.09.003

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  14 in total

1.  Distinct characteristics of endometrial and decidual macrophages and regulation of their permissivity to HIV-1 infection by SAMHD1.

Authors:  Héloïse Quillay; Hicham El Costa; Romain Marlin; Marion Duriez; Claude Cannou; Fabrice Chrétien; Hervé Fernandez; Anne Lebreton; Julien Ighil; Olivier Schwartz; Françoise Barré-Sinoussi; Marie-Thérèse Nugeyre; Elisabeth Menu
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

2.  A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes.

Authors:  Marielle Cavrois; Carlos De Noronha; Warner C Greene
Journal:  Nat Biotechnol       Date:  2002-09-30       Impact factor: 54.908

3.  Identification of preferential CD4+ T-cell targets for HIV infection in the cervix.

Authors:  V R Joag; L R McKinnon; J Liu; S T Kidane; M H Yudin; B Nyanga; S Kimwaki; K E Besel; J O Obila; S Huibner; J O Oyugi; J Arthos; O Anzala; J Kimani; M A Ostrowski; R Kaul
Journal:  Mucosal Immunol       Date:  2015-04-15       Impact factor: 7.313

4.  Increased Risk of HIV Acquisition Among Women Throughout Pregnancy and During the Postpartum Period: A Prospective Per-Coital-Act Analysis Among Women With HIV-Infected Partners.

Authors:  Kerry A Thomson; James Hughes; Jared M Baeten; Grace John-Stewart; Connie Celum; Craig R Cohen; Kenneth Ngure; James Kiarie; Nelly Mugo; Renee Heffron
Journal:  J Infect Dis       Date:  2018-06-05       Impact factor: 5.226

5.  Hormonal contraceptive use and women's risk of HIV acquisition: a meta-analysis of observational studies.

Authors:  Lauren J Ralph; Sandra I McCoy; Karen Shiu; Nancy S Padian
Journal:  Lancet Infect Dis       Date:  2015-01-09       Impact factor: 25.071

6.  Semen-derived amyloid fibrils drastically enhance HIV infection.

Authors:  Jan Münch; Elke Rücker; Ludger Ständker; Knut Adermann; Christine Goffinet; Michael Schindler; Steffen Wildum; Raghavan Chinnadurai; Devi Rajan; Anke Specht; Guillermo Giménez-Gallego; Pedro Cuevas Sánchez; Douglas M Fowler; Atanas Koulov; Jeffery W Kelly; Walther Mothes; Jean-Charles Grivel; Leonid Margolis; Oliver T Keppler; Wolf-Georg Forssmann; Frank Kirchhoff
Journal:  Cell       Date:  2007-12-14       Impact factor: 41.582

Review 7.  Contribution of sexually transmitted infections to the sexual transmission of HIV.

Authors:  Helen Ward; Minttu Rönn
Journal:  Curr Opin HIV AIDS       Date:  2010-07       Impact factor: 4.283

8.  Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysis.

Authors:  Charles S Morrison; Pai-Lien Chen; Cynthia Kwok; Jared M Baeten; Joelle Brown; Angela M Crook; Lut Van Damme; Sinead Delany-Moretlwe; Suzanna C Francis; Barbara A Friedland; Richard J Hayes; Renee Heffron; Saidi Kapiga; Quarraisha Abdool Karim; Stephanie Karpoff; Rupert Kaul; R Scott McClelland; Sheena McCormack; Nuala McGrath; Landon Myer; Helen Rees; Ariane van der Straten; Deborah Watson-Jones; Janneke H H M van de Wijgert; Randy Stalter; Nicola Low
Journal:  PLoS Med       Date:  2015-01-22       Impact factor: 11.069

9.  HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial.

Authors: 
Journal:  Lancet       Date:  2019-06-13       Impact factor: 79.321

Review 10.  Incident HIV during pregnancy and postpartum and risk of mother-to-child HIV transmission: a systematic review and meta-analysis.

Authors:  Alison L Drake; Anjuli Wagner; Barbra Richardson; Grace John-Stewart
Journal:  PLoS Med       Date:  2014-02-25       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.